Botox in below knee amputation for the management of post-operative contracture: a systematic review

Pan Afr Med J. 2024 Jan 23:47:26. doi: 10.11604/pamj.2024.47.26.42249. eCollection 2024.

Abstract

During the 1970s, scientists first used botulinum toxin to treat strabismus. While testing on monkeys, they noticed that the toxin could also reduce wrinkles in the glabella area. This led to its widespread use in both medical and cosmetic fields. The objective of the study was to evaluate the potential use of Botox in managing post-operative contracture after below-knee amputation. We conducted a systematic review In Pubmed, Cochrane Library, Embase, and Google Scholar using the MESH terms Botox, botulinum toxin, post-operative contracture, amputation, and below knee amputation. Our goal was to evaluate the potential use of Botox to manage post-operative contracture in patients who have undergone below-knee amputation. Our findings show evidence in the literature that Botox can effectively manage stump hyperhidrosis, phantom pain, and jumping stump, but no clinical trial has been found that discusses the use of Botox for post-operative contracture. Botox has been used in different ways to manage spasticity. Further studies and clinical trials are needed to support the use of Botox to manage this complication.

Keywords: Botox; below-knee amputation; botulinum toxin; muscle spasticity; post-operative contracture.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Amputation Stumps / surgery
  • Amputation, Surgical
  • Botulinum Toxins, Type A*
  • Contracture* / drug therapy
  • Contracture* / etiology
  • Contracture* / surgery
  • Humans
  • Joint Dislocations*
  • Muscle Spasticity / drug therapy
  • Neuromuscular Agents*

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents